GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
GLP-1 receptor (GLP-1R) is widely located throughout the brain, but the precise molecular mechanisms mediating the actions of GLP-1 and its long-acting analogs on adipose tissue as well as the brain areas responsible for these interactions remain largely unknown. We found that central injection of a clinically used GLP-1R agonist, liraglutide, in mice stimulates brown adipose tissue (BAT) thermogenesis and adipocyte browning independent of nutrient intake. The mechanism controlling these actions is located in the hypothalamic ventromedial nucleus (VMH), and the activation of AMPK in this area is sufficient to blunt both central liraglutide-induced thermogenesis and adipocyte browning. The decreased body weight caused by the central injection of liraglutide in other hypothalamic sites was sufficiently explained by the suppression of food intake. In a longitudinal study involving obese type 2 diabetic patients treated for 1 year with GLP-1R agonists, both exenatide and liraglutide increased energy expenditure. Although the results do not exclude the possibility that extrahypothalamic areas are also modulating the effects of GLP-1R agonists, the data indicate that long-acting GLP-1R agonists influence body weight by regulating either food intake or energy expenditure through various hypothalamic sites and that these mechanisms might be clinically relevant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beiroa (36) et al. injected GLP-1 analog, liraglutide (LIR), into mice. LIR was found to stimulate the thermogenesis of brown adipose tissue and the browning of adipose cells, independent of the intake of nutrients. It can increase the thermogenesis and utilization of triacylglycerol-derived fatty acids and glucose in brown adipocytes and reduce the lipid content through the central GLP-1R agonist”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [36]
In the citing paper
“Nevertheless, the results showed reduced or unaltered REE in both studies after treatment with GLP-1 Ras, as opposed to the first studies, where GLP-1 RAs led to a raised REE, mainly when adjusted for fat-free mass [101].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [101]
In the citing paper
“Furthermore, a central injection of liraglutide in mice stimulated thermogenesis of BAT and browning of white adipocytes independently of nutrient intake [176].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [176]
In the citing paper
“In particular, feeding activates the secretion of periprandial gut hormones, such as CCK, GLP‐1, or secretin 105, 106, 107.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [105]
Citations
Cites
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A.-H., Khandekar, M., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,319
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 4×
“In agreement with previous findings (7,17,18), we found that the central stimulation of GLP-1R reduces food intake and body weight.”
BackgroundResultInfluentialGlucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundBuse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503 · cited 9×
“In addition to the functional data on liraglutide from the mouse study, we analyzed data from a cohort of obese patients with T2D who had been treated for 1 year with the antidiabetic drugs metformin and metformin in combination with the GLP-1R agonists exenatide and liraglutide (Table 1).”
BackgroundInfluentialPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundAstrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P. A., Rodriguez-Pattzi, H., Olvera-Alvarez, I., Hale, P. M., Zdravkovic, M., & Bode, B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61246-5 · Cited by 1,057
Cited by
Items 401–500 of 598
Beyond obesity – thermogenic adipocytes and cardiometabolic health
Aldiss, P., Dellschaft, N. S., Sacks, H. S., Budge, H., & Symonds, M. E. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0007 · Cited by 12
Kaineder, K., Birngruber, T., Rauter, G., Obermüller, B., Eichler, J., Münzker, J., Al-Zoughbi, W., Mautner, S., Torekov, S. S., Hartmann, B., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.98 · Cited by 15
PAS Kinase: A Nutrient and Energy Sensor “Master Key” in the Response to Fasting/Feeding Conditions
Hurtado-Carneiro, V., Pérez-García, A., Álvarez, E., & Sanz, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.594053 · Cited by 11
Development of CIDEA reporter mouse model and its application for screening thermogenic drugs
Son, Y., Choi, C., Song, C. O., Im, H., Cho, Y. K., Son, J. S., Joo, S., Joh, Y., Lee, Y. J., Seong, J. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97959-0 · Cited by 11
Zain, S., Shamshad, T., Kabir, A., & Khan, A. A. (2023) · Cureus · doi:10.7759/cureus.46153 · Cited by 15
Glucagon-like peptide-1 receptor agonists in neoplastic diseases
Ji, L., He, X., Min, X., Yang, H., Wu, W., Xu, H., Chen, J., & Mei, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1465881 · Cited by 12
Rheumatic diseases and metabolism: where centre and periphery meet
López, M., & Gualillo, O. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01178-6 · Cited by 13
“…193 , bone morphogenetic protein 8B 154,158,194 and, importantly, pharmacological agents with well-known anti-obesity effects, such as liraglutide 153 and nicotine 152 , all act (among other mechanisms) by inhibiting hypothalamic AMPK signalling in the VMH to elicit the thermogenic activation of…”
Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
Hankir, M. K., & Lutz, T. A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03047-3 · Cited by 16
“…systemically administered, fluorescently labeled liraglutide and semaglutide gain access to the median eminence and ARC and to a lesser extent the PVH and DMH [51, 126], while administration of liraglutide into the ARC, PVH, and LHA (but not the DMH and VMH) robustly reduces food intake [120, 127].”
Thermogenic adipose tissues: Promising therapeutic targets for metabolic diseases
Pahlavani, M., Pham, K., Kalupahana, N. S., Morovati, A., Ramalingam, L., Abidi, H., Kiridana, V., & Moustaïd‐Moussa, N. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109832 · Cited by 12
Novel therapeutics in rare genetic obesities: A narrative review
Dubern, B., Faccioli, N., Poitou, C., & Clément, K. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106763 · Cited by 16
Anti-Diabetic and Anti-Adipogenic Effect of Harmine in High-Fat-Diet-Induced Diabetes in Mice
Morsy, M. H. E., Nabil, Z. I., Darwish, S. T., Al-Eisa, R. A., & Mehana, A. E. (2023) · Life · doi:10.3390/life13081693 · Cited by 14
Ruocco, C., Malavazos, A. E., Ragni, M., Carruba, M. O., Valerio, A., Iacobellis, G., & Nisoli, E. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106892 · Cited by 10
“Interestingly, GLP1R agonists can reduce EAT inflammation and increase FFA oxidation as fuel for the myocardium, and induce fat browning, and GLP1R-dependent browning effect on EAT can lead to improved myocardial insulin sensitivity and metabolism [306].”
Targeting obesity for therapeutic intervention in heart failure patients
Sato, R., & von Haehling, S. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2363395 · Cited by 10
“GLP-1 analogue also leads to significant weight loss by prolonging gastric emptying, acting on hypothalamic neurons to induce satiety, increasing lipolysis, and stimulating brown adipose tissue thermogenesis (Table 1) [120–125].”
BackgroundBrown adipose tissue and its therapeutic application
Yuan, X., Dong, M., Lee, H. J., & Jin, W. (2016) · 中国科学通报:英文版 · doi:10.1007/s11434-016-1051-9 · Cited by 11
“Both glucagon-like peptide 1 receptor (GLP-1R) [74, 75] and its agonist liraglutide [76] increase thermogenesis in BAT and induce browning within WAT.”
BackgroundThe color of fat and its central role in the development and progression of metabolic diseases
Gaggini, M., Carli, F., & Gastaldelli, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0060 · Cited by 12
“GLP-1 receptor agonists (GLP-1 RA) therapy is associated with weight loss and both liraglutide and exenatide (two currently approved GLP-1 RA) have been shown to activate cerebral GLP-1R [56] and to increase energy expenditure [103].”
BackgroundCuñarro, J., Buqué, X., Casado, S., Lugilde, J., Vidal, A., Mora, A., Sabio, G., Nogueiras, R., Aspichueta, P., Diéguez, C., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801096 · Cited by 12
Self-citationMartín, M., Rodríguez, A., Gómez‐Ambrosi, J., Ramírez, B., Becerril, S., Catalán, V., López, M., Diéguez, C., Frühbeck, G., & Burrell, M. A. (2021) · Nutrients · doi:10.3390/nu13072128 · Cited by 10
“In addition to improving glycemia [29], GLP-1 reduces appetite, thereby supporting its use in the treatment of obesity and its comorbidities [30,31].”
BackgroundSelf-citationInfluence of modern antidiabetic therapy on body weight in patients with type 2 diabetes mellitus
Салухов, В. В., Ilyinskaya, Т. A., & Minakov, A. A. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-1-39-52 · Cited by 13
Folgueira, C., Torres‐Leal, F. L., Beiroa, D., Pena-León, V., Lima, N. D. S., Milbank, E., Senra, A., Al–Massadi, O., López, M., Diéguez, C., et al. (2020) · Neuroendocrinology · doi:10.1159/000505972 · Cited by 10
Self-citationShah, H., & Ayala, J. E. (2025) · Diabetes · doi:10.2337/db25-0678 · Cited by 16
Strategies and methods for the correction of obesity and associated cardiovascular risk
Kuznetsova, Т. Y., Druzhilov, М. A., Chumakova, G. A., & Veselovskaya, N. G. (2019) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2019-4-61-67 · Cited by 11
Pan, R., Liu, J., & Chen, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1144918 · Cited by 12
“Ulteriorly, it was demonstrated that central injection of the GLP-1R agonist, liraglutide, in mice could stimulate thermogenesis in BAT and beiging in WAT by activating AMPK in the hypothalamic ventromedial nucleus (Beiroa et al., 2014).”
BackgroundDo anti-obesity medical treatments have a direct effect on adipose tissue?
Vergès, B. L. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.05.021 · Cited by 10
Pham, H. G., Dang, T. T. H., & Yun, J. W. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104475 · Cited by 9
Park, S., & Kim, E. (2024) · Metabolites · doi:10.3390/metabo14090483 · Cited by 8
Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota
Herz, C. T., Kulterer, O. C., Prager, M., Marculescu, R., Prager, G., Kautzky‐Willer, A., Hacker, M., Trajanoski, S., Köfeler, H. C., Gallé, B., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf081 · Cited by 11
Herman, R., Jensterle, M., Horvat, S., Ležaić, L., Snoj, Ž., Pušnik, I., Goričar, K., Cör, A., Pušnik, L., Mlačnik, V., et al. (2025) · Trials · doi:10.1186/s13063-025-09045-9 · Cited by 14
Neff, G. W. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70148 · Cited by 13
Zhou, Y., Yan, H., Zhu, Y., Jiang, W., & Zhang, S. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1701459 · Cited by 11
Thermogenesis in Adipose Tissue: Adrenergic and Non-Adrenergic Pathways
Hossain, M. A., Poojari, A., & Rabiee, A. (2026) · Cells · doi:10.3390/cells15020131 · Cited by 10
“For instance, administering liraglutide, a long-acting analog, via central routes activates GLP-1 receptors in the ventromedial nucleus of the hypothalamus (VMH) [87].”
Cicuéndez, B., Pérez-García, J., & Folgueira, C. (2024) · Nutrients · doi:10.3390/nu16030424 · Cited by 8
“A stereotaxic surgery procedure was employed to implant an intracerebrovascular (ICV) cannula in the lateral ventricle of the hypothalamus (coordinates: 1.3 mm posterior to bregma and 1.9 mm lateral to the midsagittal suture at a depth of 3.5 mm), as previously described [27].”
MethodInfluentialMolecular epigenetics in the transition of white to brown fat
Chaturvedi, S., Chaturvedi, P., Gupta, P. C., Awasthi, S. K., & Kalani, A. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156073 · Cited by 10
Díaz, M., García-Beltrán, C., López‐Bermejo, A., de Zegher, F., & Ibáñez, L. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.271 · Cited by 8
Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy
Iacobellis, G., Basilico, S., & Malavazos, A. E. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_577 · Cited by 8
Lessons from a cardiovascular outcome trial with liraglutide in type 2 diabetes
Kim, H. J., & Kim, D. J. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12607 · Cited by 8
Mao, L., Lei, J., Schoemaker, M. H., Ma, B., Zhong, Y., Lambers, T. T., van Tol, E. A. F., Zhou, Y., Nie, T., & Wu, D. (2018) · Food & Function · doi:10.1039/c7fo01835e · Cited by 8
Song, R., Qian, H., Wang, Y., Li, Q., Li, D., Chen, J., Yang, J., Zhong, J., Yang, H., Min, X., et al. (2022) · Journal of Diabetes Research · doi:10.1155/2022/4554996 · Cited by 10
“Animal studies have shown that GLP-1RA specifically binds to the GLP-1 receptor in the central system to stimulate the thermogenesis of brown adipose tissue and the browning of white adipose tissue, reduce food intake, and increase energy consumption [73].”
Katsiki, N., & Mikhailidis, D. P. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29573 · Cited by 8
“Limited data support the effect of statins, GLP‐1 RAs, and empagliflozin on fat phenotype (Beiroa et al., 2014; González, Moreno‐Villegas, González‐Bris, Egido, & Lorenzo, 2017; Xu et al., 2017).”
BackgroundAn insoluble cellulose nanofiber with robust expansion capacity protects against obesity
Yu, J. G., Gao, M., Wang, L., Guo, X., Liu, X., Sheng, M., Cheng, S., Guo, Y., Wang, J., Zhao, C., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134401 · Cited by 9
Harada, K., Wada, E., Osuga, Y., Shimizu, K., Uenoyama, R., Hirai, M. Y., Maekawa, F., Miyazaki, M., Hayashi, Y. K., Nakamura, K., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102072 · Cited by 9
Incorporating Postbiotics into Intervention for Managing Obesity
Hijová, E., Bertková, I., & Štofilová, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115362 · Cited by 7
“Activating hypothalamic AMPK stimulates appetite and promotes weight gain, while inhibiting it leads to weight loss [37,38].”
Aging-induced dysfunction of adipose tissue and skeletal muscle and its link to insulin resistance
Sakaguchi, M. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvaf081 · Cited by 12
Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control
Deng, Y., Deng, G., Grobe, J. L., & Cui, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.691226 · Cited by 8
Orally Induced Hyperthyroidism Regulates Hypothalamic AMP-Activated Protein Kinase
Capelli, V., Grijota-Martínez, C., Dragano, N. R. V., Rial‐Pensado, E., Fernø, J., Nogueiras, R., Mittag, J., Diéguez, C., & López, M. (2021) · Nutrients · doi:10.3390/nu13124204 · Cited by 7
Self-citationXu, Z., Li, H., Cao, G., Li, P., Zhou, H., & Sun, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02326-3 · Cited by 8
“In addition, β-AR agonists [41], glucagon-like peptide 1 receptors [42], and FGF21 [43] can directly act on BAT.”
BackgroundZhou, F., Jiang, L., Guo, J., Fan, Y., Pan, Q., Li, T., Sun, X., & Li, P. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231161516 · Cited by 7
Yin, R., Ma, Y., Zhang, N., Yang, L., & Zhao, D. (2022) · The Chinese Journal of Physiology · doi:10.4103/cjp.cjp_87_21 · Cited by 7
Carreira, M. C., Andrade, S., Izquierdo, A. G., Amil, M., Folgueira, C., Monteiro, M. P., Sanz, E., Crujeiras, A. B., & Casanueva, F. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-34840-7 · Cited by 7
Effect of Liraglutide on Intermittent Hypoxia‐Induced Metabolic Dysfunction: From Bench to Bedside
O’Donnell, C., King, A., Vial, G., O'Neill, E., Crilly, S., Dodd, J. D., Murphy, D. J., Belaïdi, E., Pépin, J., Arnaud, C., et al. (2025) · Journal of Sleep Research · doi:10.1111/jsr.70152 · Cited by 6
“In addition, accumulating evidence supports their direct effect on the AT through attenuation of inflammation and ‘browning’ with downstream effects of improved metabolic function (Beiroa et al. 2014; Lee et al. 2012; Lynch et al. 2016).”
Basolo, A., Paolucci, G., Piaggi, P., Angeli, V., Genzano, S. B., Fierabracci, P., Vignali, E., Bologna, C., Salvetti, G., Chiovato, L., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02717-y · Cited by 10
“However, most of the included studies were conducted in individuals with type 2 diabetes and did not employ gold-standard methodologies such as whole-room indirect calorimetry over 24 h for measuring energy metab - olism [ 48 –50].”
Byun, S., Sotzen, M. R., Knappenberger, M. A., Bento, M. T., Asker, M., Olekanma, D. I., & Skibicka, K. P. (2025) · Comprehensive physiology · doi:10.1002/cph4.70083 · Cited by 8
“Central GLP-1R activation through intra-cerebroventricular delivery of GLP-1 analogues not only stimulates sympathetic outflow to BAT, thereby increasing UCP1 expression and thermogenesis (Lockie et al. 2012), but also recruits beige adipocytes in WAT (Beiroa et al. 2014), at least in male mice.”
Aguggia, J. P., Fernández, G., Cassano, D., Mustafá, E. R., Rodríguez, S., Cantel, S., Fehrentz, J., Raingo, J., Schiöth, H. B., Habib, A. M., et al. (2024) · Endocrinology · doi:10.1210/endocr/bqae160 · Cited by 6
Mechanistic insights into GLP-1 receptor agonist-induced weight loss through ceRNA network analysis
Li, W., Zhang, X., Song, J., Yang, L., Wang, D., Yuan, G., & Zhao, L. (2025) · Genomics · doi:10.1016/j.ygeno.2025.110988 · Cited by 7
Li, B., Gao, Y., Wang, W., Zhu, R., Yang, X., Chen, H., Wang, X., & Gu, H. (2025) · Academic Radiology · doi:10.1016/j.acra.2025.04.015 · Cited by 7
The management of hypothalamic obesity in craniopharyngioma
Dimitri, P. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102018 · Cited by 6
Pharmacological Mechanisms of Boiogito and Bofutsushosan in Diabetes and Obesity Models
Kobayashi, S. (2018) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.17-00168 · Cited by 6
Survivin is essential for thermogenic program and metabolic homeostasis in mice
Alimujiang, M., Sun, J., Chen, S., Bai, N., Chen, S., Hu, F., Ma, J., Xu, Y., Xu, J. Y., Ma, X., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101446 · Cited by 6
Ide, S., Yamamoto, M., Takemoto, M., Fujimoto, M., Ide, K., Kobayashi, K., & Yokote, K. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13970 · Cited by 7
“Liraglutide has recently been reported to stimulate brown adipose tissue thermogenesis and browning through hypothalamic adenosine monophosphate–activated protein kinase.(5) This mechanism may also contribute to a decrease in visceral fat.”
BackgroundChen, L.-S., & Liu, L. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.07.024 · Cited by 5
Perivascular adipose tissue in cardiovascular disease: From mechanisms to therapeutic targets
Ueda, K. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2025.08.001 · Cited by 5
Mestres‐Arenas, A., Quesada‐López, T., Blasco‐Roset, A., Giralt, M., Villarroya, F., Planavila, A., & Peyrou, M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119057 · Cited by 8
Self-citationPolu, P. R. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100686 · Cited by 7
Petersen, E. A., Blom, I., Melander, S. A., Al-Rubai, M., Vidotto, M., Dalgaard, L. T., Karsdal, M. A., Henriksen, K., Larsen, S., & Larsen, A. T. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01564-w · Cited by 8
Effects of Weight Loss on Endothelium and Vascular Homeostasis: Impact on Cardiovascular Risk
Tiezzi, M., Sega, F. V. D., Gentileschi, P., Campanelli, M., Benavoli, D., & Tremoli, E. (2025) · Biomedicines · doi:10.3390/biomedicines13020381 · Cited by 5
“In healthy subjects, acylated ghrelin improves cardiac functional parameters, but not endothelial function [83,84].”
Schooling, C. M., Yang, G., Soliman, G. A., & Leung, G. M. (2025) · Life · doi:10.3390/life15020253 · Cited by 9
“AMPK activation also GLP1-RA acting via the ventromedial hypothalamus has been shown to reduce food intake in mice and rats [37,38] due to AMPK activation [39]. reduces inflammation [48], as seen for semaglutide [49], meaning that inflammation might be an aspect of AMPK suppression causing…”
Mamontova, E. D., Michurina, S. S., Stafeev, I., Sorkina, E., Sklyanik, I. A., Koksharova, E., Menshikov, M. Y., Shestakova, M. V., & Parfyonova, Y. V. (2021) · Biochemistry (Moscow) · doi:10.1134/s000629792103010x · Cited by 5
Nagagata, B. A., Brito, G. C., Ornellas, F., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109625 · Cited by 5
AMPK-Mediated Multi-Organ Protective Effects of GLP-1 Receptor Agonists
Wang, X., & Wang, L. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100004 · Cited by 7
“Additionally, activation of AMPK in the VMH reduces liraglutide-induced UCP1 expression in BAT and WAT of rats [81] .”
Incretin Hormones in the Control of Immunometabolism
Fishman, S., Zvibel, I., & Varol, C. (2019) · Immunometabolism · doi:10.20900/immunometab20190004 · Cited by 6
“Very recent studies have demonstrated that administration of liraglutide directly into the hypothalamic ventral nucleus stimulates BAT thermogenesis and adipocyte browning, independently of food intake [76].”
BackgroundNEW INSIGHTS INTO BROWN ADIPOSE TISSUE AS A PHARMACOLOGICAL TARGET IN OBESITY
Andrei, A. M. (2020) · FARMACIA · doi:10.31925/farmacia.2020.1.1 · Cited by 5
“studies in mice demonstrated that it stimulates BAT thermogenesis, WAT browning and reduces food intake [3, 59].”
BackgroundAnalyzing AMPK Function in the Hypothalamus
Seoane‐Collazo, P., & López, M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7598-3_27 · Cited by 5
Cellular energy sensors: AMPK and beyond
López, M., & Diéguez, C. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.007 · Cited by 4
A novel gene therapy platform for the treatment of type 2 diabetes and obesity
Lourie, J., Goraltchouk, A., Hollander, J. M., BERGER, N. J. A., Rosen, H. G., Fujishiro, A. A., Luppino, F., Seregin, A., Rhym, L. H., & Zou, K. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102739 · Cited by 6
“Previous studies have shown that GLP-1 receptor signaling can regulate key physiological processes involved in whole-body energy metabolism, including promoting energy expenditure 66,67 and stimulating lipolysis.”
Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
Kourtidou, C., & Τζιόμαλος, Κ. (2023) · Biomedicines · doi:10.3390/biomedicines11020496 · Cited by 7
“These studies showed the potential relationship between GLP-1 agonism and inhibition of fatty acid synthase expression [31], brown adipose tissue thermogenesis mediated by AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT-1) [32,34] and lipolysis and fatty acid oxidation mediated by SIRT-1 [33].”
Liraglutide modulates lipid metabolism via ZBTB20-LPL pathway
Li, Y., Gao, R., Yang, Z., Zong, H., & Li, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123267 · Cited by 4
Counteracting health risks by Modulating Homeostatic Signaling
Tian, J. J., Levy, M. A., Zhang, X., Sinnott, R., & Maddela, R. L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106281 · Cited by 4
HYPOTHesizing about central comBAT against obesity
González‐García, I., Milbank, E., Martínez-Ordóñez, A., Diéguez, C., López, M., & Contreras, C. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00719-y · Cited by 7
“(2) PKA activates p38-mitogen activated kinase (p38MAPK) inducing transcriptional effects in the nucleus for UCP1 synthesis.”
BackgroundInfluentialCampos, C. (2018) · PubMed · Cited by 4
Bittencourt, J. D. O. A., Marcondes‐de‐Castro, I. A., Marinho, T. D. S., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124155 · Cited by 3
Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes
Abbasi, M., Sun, K., Huggins, K. W., Heath, B., DeLoit, H., McGinness, L., & Mccamy, K. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.035 · Cited by 10
“…within the hypothalamic ventromedial nucleus, increases energy expenditure and decreases fat accumulation by activating brown adipose tissue (BAT) and promoting the browning of white adipose tissue (WAT) through AMP-activated protein kinase signaling, independent of food intake changes 43,44 .”
Microbial reprogramming of the gut-liver nexus in MASLD: Lessons from Akkermansia muciniphila
Liu, Y., Targher, G., Byrne, C. D., Jiang, C., Tan, Z., Tilg, H., Yu, J., He, Z., Yin, Y., Zheng, M., et al. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100031 · Cited by 3
Liraglutide prevents body and fat mass gain in ovariectomized Wistar rats
Rossetti, C. L., Andrade, I. S., Boa, L. F. F., Neves, M. B., Fassarella, L. B., Bertasso, I. M., de Souza, M. D. G. C., Bouskela, E., Lisboa, P. C., Takyia, C. M., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112374 · Cited by 3
Xu, Z., Wen, S., Dong, M., & Zhou, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16146 · Cited by 4
“66 Furthermore, empirical evidence indicates that liraglutide enhances the upregulation of UCP-1 and oxygen consumption induced by β 3-adrenergic signalling in BAT and subcutaneous WAT.”
Regulation of the Energy Balance
Vieira, E. E. S., Lima, N. D. S., de Matos‐Neto, E. M., & Torres‐Leal, F. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816093-0.00018-5 · Cited by 5
Glucagon-Like Peptide-1 Is Involved in the Thermic Effects of Dietary Proteins in Male Rodents
Ochiai, K., Muto, A., Seok, B. S., Doi, Y., Iwasaki, Y., Okamatsu‐Ogura, Y., Drucker, D. J., & Hira, T. (2023) · Endocrinology · doi:10.1210/endocr/bqad068 · Cited by 3
GPCR-mediated regulation of beige adipocyte formation: Implications for obesity and metabolic health
Cui, Y., Auclair, H., He, R., & Zhang, Q. (2024) · Gene · doi:10.1016/j.gene.2024.148421 · Cited by 4
Influence of high fat and different types of carbohydrate diet on energy metabolism in growing mice
Chung, N., & Lim, K. (2019) · Physical Activity and Nutrition · doi:10.20463/jenb.2019.0017 · Cited by 3
The active ingredients in the anti‐obesity drug bofutsushosan in high‐fat‐diet‐fed obese mice
Takahashi, T., Hori, K., Yoshida, E., Ikeda‐Matsuo, Y., Shimada, T., Nomura, M., & Kobayashi, S. (2020) · Traditional & Kampo Medicine · doi:10.1002/tkm2.1253 · Cited by 3
“Moreover, mechanisms by which geniposide-induced central GLP-1 stimulation reduces body weight may involve food intake, decreased lipid storage in WAT, and increased BAT thermogenesis [24,25].”
BackgroundHave a heart: failure to increase GLP-1 caused by heart failure increases the risk of diabetes
Ryan, M. J. (2020) · Clinical Science · doi:10.1042/cs20201029 · Cited by 3
Bombassaro, B., Batitucci, G., Simoes, M. R., ARAUJO, E. P. D., & Velloso, L. A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1626068 · Cited by 4
Molecular Mechanisms Against Successful Weight Loss and Promising Treatment Options in Obesity
Szekeres, Z., Szabados, E., & Pálfi, A. (2025) · Biomedicines · doi:10.3390/biomedicines13081989 · Cited by 4
Salagre, D., Mosqueda, C. V. A., Aouichat, S., & Agil, A. (2025) · Pharmaceuticals · doi:10.3390/ph18091247 · Cited by 2
“In rodents, liraglutide (C 172 H 265 N 43 O 51 ), a long-acting GLP-1 receptor agonist, stimulated BAT thermogenesis and promoted WAT browning, resulting in reduced body weight and food intake [116].”
Thermogenic Targets for Obesity Management in the Era of Incretin-Based Therapies
Soliman, S., Andrews‐Dickert, R., Ročić, P., & Mitov, M. I. (2025) · Pharmaceuticals · doi:10.3390/ph18101519 · Cited by 3
“…activation of thermogenic programs in brown adipose tissue (BAT), with targeted injection of liraglutide into the ventromedial hypothalamus sufficient to induce weight loss and stimulate BAT thermogenesis through 5 ′ adenosine monophosphate-activated protein kinase (AMPK)-dependent signaling [13].”
Effects of GLP-1 receptor agonists and dual incretin agonists on adipocyte type and size
Turashvili, N. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101452 · Cited by 2
Incretin-Based Therapies: A Novel Pathway in Addiction Treatment
Rosiejka, D., Joanna, M., Marcickiewicz, J., Bogdańska, A., Błażejewska, W., & Szulińska, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041613 · Cited by 2
GLP-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal?
Piras, G., Brasili, S., Demontis, D., Sala, L. D., Cocchiara, F., Maggi, D. C., & Arecco, A. (2026) · Diabetology · doi:10.3390/diabetology7030050 · Cited by 2
The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms
Davies, I., Holst, J. J., ROSENKILDE, M. M., & Tan, T. (2026) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061824-043740 · Cited by 3
Repetti, G. G., Abel, E. D., Tontonoz, P., & Sallam, T. (2026) · Circulation Research · doi:10.1161/circresaha.126.328680 · Cited by 3
Braha, A., Timar, B., Sturza, A., & Timar, R. Z. (2026) · Medicina · doi:10.3390/medicina62081509 · Cited by 2
“Moreover, GLP-1 RAs stimulate brown adipose tissue thermogenesis and browning through hypothalamic AMPK [53].”
Role of Nutrient and Energy Sensors in the Development of Type 2 Diabetes
Hurtado-Carneiro, V., Pérez-García, A., Álvarez, E., & Sanz, C. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95454 · Cited by 4
Metadata
- Authors
- Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., Dieguez, C., Lopez, M., Frühbeck, G., & Nogueiras, R.
- Affiliations
- Universidade de Santiago de Compostela (ES)
- Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Spanish National Cancer Research Centre (ES)
- Centro de Investigación Biomédica en Red (ES)
- University of Bergen (NO)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-09-15
- Volume
- 63
- Issue
- 10
- Pages
- 3346-3358
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2108365604
- Cited by
- 602
- References
- 52
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 60 · 2023: 51 · 2022: 57 · 2021: 59 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 43 · 2016: 49 · 2015: 41 · 2014: 8
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- GLP-1 receptor agonists, liraglutide, exenatide, brown adipose tissue thermogenesis, adipocyte browning, ventromedial hypothalamus, AMPK, energy expenditure, food intake regulation, body weight, obesity, type 2 diabetes, central nervous system
- MeSH terms
- Liraglutide, Exenatide, AMP-Activated Protein Kinase Kinases, Adult, Aged, Aged, 80 and over, Animals, Adipose Tissue, Brown, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Eating, Energy Metabolism, Female, Humans, Hypoglycemic Agents, Hypothalamus, Male, Metformin, Middle Aged, Obesity, Peptides, Protein Kinases, Venoms, Thermogenesis, Mice, Rats, Glucagon-Like Peptide 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.